DiaMedica Therapeutics to Present at Credit Suisse 31st Annual Healthcare Conference

Author's Avatar
Oct 31, 2022

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today announced that Rick Pauls, its President and CEO, will present a corporate overview at the Credit Suisse 31st Annual Healthcare Conference, which will take place November 8 – 10, 2022 in Rancho Palos Verdes, California.